Kappos L - Search Results

1

Use of composite scores in the quantification of deterioration in multiple sclerosis.

Lienert C, Lechner-Scott J, Schött D, Constantinescu C, Kappos L. Lienert C, et al. Among authors: kappos l. Mult Scler. 1999 Aug;5(4):220-2. doi: 10.1177/135245859900500405. Mult Scler. 1999. PMID: 10467379 Review. No abstract available.

2

[Hereditary motor and sensory neuropathies. Clinical and molecular genetic aspects].

Lechner-Scott JS, Scott RJ, Steck AJ, Kappos L. Lechner-Scott JS, et al. Among authors: kappos l. Schweiz Arch Neurol Psychiatr (1985). 1995;146(4):157-67. Schweiz Arch Neurol Psychiatr (1985). 1995. PMID: 8533057 Review. German.

3

[Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].

Huber S, Spycher M, Lechner-Scott J, Bellaiche Y, Steck AJ, Kappos L. Huber S, et al. Among authors: kappos l. Schweiz Med Wochenschr. 1996 Aug 31;126(35):1475-81. Schweiz Med Wochenschr. 1996. PMID: 8927950 Clinical Trial. German.

4

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radü EW, Steck A, Leenders KL. Roelcke U, et al. Among authors: kappos l. Neurology. 1997 Jun;48(6):1566-71. doi: 10.1212/wnl.48.6.1566. Neurology. 1997. PMID: 9191767

5

Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial.

Poehlau D, Federlein J, Postert T, Sailer M, Bethke F, Kappos L, Haas J, Przuntek H. Poehlau D, et al. Among authors: kappos l. Mult Scler. 1997 Apr;3(2):149-52. doi: 10.1177/135245859700300217. Mult Scler. 1997. PMID: 9291171 Clinical Trial.

6

Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.

Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, Pozilli C. Polman CH, et al. Among authors: kappos l. Mult Scler. 1995;1 Suppl 1:S51-4. Mult Scler. 1995. PMID: 9345400 Clinical Trial.

7

Interferon beta in the treatment of multiple sclerosis--closing remarks.

Kappos L. Kappos L. Mult Scler. 1995;1 Suppl 1:S64-6. Mult Scler. 1995. PMID: 9345403 Review. No abstract available.

8

Combinations of drugs.

Kappos L. Kappos L. Mult Scler. 1996 Jul;1(6):400-3. doi: 10.1177/135245859600100624. Mult Scler. 1996. PMID: 9345426

9

Computer assisted retraining of attentional impairments in patients with multiple sclerosis.

Plohmann AM, Kappos L, Ammann W, Thordai A, Wittwer A, Huber S, Bellaiche Y, Lechner-Scott J. Plohmann AM, et al. Among authors: kappos l. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):455-62. doi: 10.1136/jnnp.64.4.455. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576535 Free PMC article. Clinical Trial.

10

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Among authors: kappos l. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters